At a glance
ClinicalIndex Comparison RecordN/ACompleted· 33 enrolled
Drug / intervention
Turmeric and Black Cumin Seed +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Single-blind, Placebo-controlled Study to Evaluate the Effects of a Turmeric and Black Cumin Seed Formulation on Cholesterol Levels Among Generally Healthy Participants
In Brief
A clinical study evaluating Turmeric and Black Cumin Seed and Placebo for Cholesterol Health. Completed, enrolled 33 participants across 1 site.
Detailed Summary
The purpose of this study is to assess the effects of a turmeric and black cumin seed formulation on cholesterol levels.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCholesterol Health
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartMay 2017
First PostedJun 2017
Primary CompletionAug 2018
Study CompletionAug 2018
TodayJul 2026
First PostedJun 5, 2017
Enrollment StartMay 12, 2017
Primary CompletionAug 10, 2018
Study CompletionAug 16, 2018
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 9.1 years ago
Interventions
Turmeric and Black Cumin Seeddietary
Turmeric and Black Cumin Seed formulation
Placebodietary
Placebo